NDC11 71209001210
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71209-0012-10 | 71209-0012 |
| 71209-012-10 | 71209-012 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Cadila Pharmaceuticals Limited | e7e641fe-39bd-4681-a430-6dedeb6d6af5 | 2022-12-29 | Warnings, Adverse reactions | 71209-012-10 71209-012 71209001210 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.